Obesity and Urolithiasis

Advances in Chronic Kidney Disease

Volumn 16, Issue 1, 2009, Pages 11-20

  Asplin, John R ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Bariatric surgery; Low carbohydrate diet; Metabolic syndrome; Uric acid; Urine pH

Indexed keywords

ACID BASE BALANCE; AMMONIA FORMATION; ARTICLE; BARIATRIC SURGERY; BODY MASS; CALCIUM OXALATE STONE; CALCIUM STONE; DIETARY INTAKE; DISEASE ASSOCIATION; HEALTH HAZARD; HUMAN; HYPEROXALURIA; INCIDENCE; INSULIN RESISTANCE; LOW CARBOHYDRATE DIET; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL; STONE FORMATION; UNITED STATES; URIC ACID STONE; URINE PH; UROLITHIASIS; WEIGHT CONTROL; WEIGHT REDUCTION;

BARIATRIC SURGERY; HUMANS; OBESITY; POSTOPERATIVE COMPLICATIONS; PREVALENCE; RISK FACTORS; UNITED STATES; UROLITHIASIS;

EID: 57649099214     PISSN: 15485595     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ackd.2008.10.003     Document Type: Article

References (68)

1. Goldfarb D.S., Fischer M.E., Keich Y., et al. A twin study of genetic and dietary influences on nephrolithiasis: a report from the Vietnam Era Twin (VET) Registry. Kidney Int 67 (2005) 1053-1061
2. Trinchieri A., Coppi F., Montanari E., et al. Increase in the prevalence of symptomatic upper urinary tract stones during the last ten years. Eur Urol 37 (2000) 23-25
3. Serio A., and Fraioli A. Epidemiology of nephrolithiasis. Nephron 81 (1999) 26-30
4. Stamatelou K.K., Francis M.E., Jones C.A., et al. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int 63 (2003) 1817-1823
5. Archenti A., and Pasqualinotto L. Childhood obesity: The epidemic of the third millenium. Acta Biomed 79 (2008) 151-155
6. Wang Y., Beydoun M.A., Liang L., et al. Will all Americans become overweight or obese? Estimating the progression and cost of the US obesity epidemic. Obesity 16 (2008) 2323-2330
7. Ogden C.L., Carroll M.D., Curtin L.R., et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295 (2006) 1549-1555
8. Roth J., Qiang X., Marban S.L., et al. The obesity pandemic: where have we been and where are we going?. Obes Res 12 Suppl 2 (2004) 88S-101S
9. Nielsen S.J., and Popkin B.M. Patterns and trends in food portion sizes, 1977-1998. JAMA 289 (2003) 450-453
10. Flegal K.M., Carroll M.D., Ogden C.L., et al. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 288 (2002) 1723-1727
11. Taylor E.N., Stampfer M.J., and Curhan G.C. Obesity, weight gain, and the risk of kidney stones. JAMA 293 (2005) 455-462
12. Powell C.R., Stoller M.L., Schwartz B.F., et al. Impact of body weight on urinary electrolytes in urinary stone formers. Urology 55 (2000) 825-830
13. Siener R., Glatz S., Nicolay C., et al. The role of overweight and obesity in calcium oxalate stone formation. Obes Res 12 (2004) 106-113
14. Taylor E.N., and Curhan G.C. Body size and 24-hour urine composition. Am J Kidney Dis 48 (2006) 905-915
15. Gross L.S., Li L., Ford E.S., et al. Increased consumption of refined carbohydrates and the epidemic of type 2 diabetes in the United States: An ecologic assessment. Am J Clin Nutr 79 (2004) 774-779
16. Shapiro A., Mu W., Roncal C.A., et al. Fructose-induced leptin resistance exacerbates weight gain in response to subsequent high fat feeding. Am J Physiol Regul Integr Comp Physiol 295 (2008) R1370-R1375
17. Koh E.T., Reiser S., and Fields M. Dietary fructose as compared to glucose and starch increases the calcium content of kidney of magnesium-deficient rats. J Nutr 119 (1989) 1173-1178
18. Milne D.B., and Nielsen F.H. The interaction between dietary fructose and magnesium adversely affects macromineral homeostasis in men. J Am Coll Nutr 19 (2000) 31-37
19. Fox I.H., and Kelley W.N. Studies on the mechanism of fructose-induced hyperuricemia in man. Metabolism 21 (1972) 713-721
20. Taylor E.N., and Curhan G.C. Fructose consumption and the risk of kidney stones. Kidney Int 73 (2008) 207-212
21. Pi-Sunyer X: The metabolic syndrome: how to approach differing definitions. Med Clin North Am 91 (2007) 1025-1040
22. Lieske J.C., de la Vega L.S., Gettman M.T., et al. Diabetes mellitus and the risk of urinary tract stones: A population-based case-control study. Am J Kidney Dis 48 (2006) 897-904
23. Taylor E.N., Stampfer M.J., and Curhan G.C. Diabetes mellitus and the risk of nephrolithiasis. Kidney Int 68 (2005) 1230-1235
24. Daudon M., Traxer O., Conort P., et al. Type 2 diabetes increases the risk for uric acid stones. J Am Soc Nephrol 17 (2006) 2026-2033
25. Asplin J. Uric acid stones. Semin Nephrol 16 (1996) 412-424
26. Pak C.Y., Sakhaee K., Peterson R.D., et al. Biochemical profile of idiopathic uric acid nephrolithiasis. Kidney Int 60 (2001) 757-761
27. Coe F.L., Strauss A.L., Tembe V., et al. Uric acid saturation in calcium nephrolithiasis. Kidney Int 17 (1980) 662-668
28. Maalouf N.M., Sakhaee K., Parks J.H., et al. Association of urinary pH with body weight in nephrolithiasis. Kidney Int 65 (2004) 1422-1425
29. Cameron M.A., Maalouf N.M., Adams-Huet B., et al. Urine composition in type 2 diabetes: predisposition to uric acid nephrolithiasis. J Am Soc Nephrol 17 (2006) 1422-1428
30. Sakhaee K., Adams-Huet B., Moe O.W., et al. Pathophysiologic basis for normouricosuric uric acid nephrolithiasis. Kidney Int 62 (2002) 971-979
31. Maalouf N.M., Cameron M.A., Moe O.W., et al. Low urine pH: A novel feature of the metabolic syndrome. Clin J Am Soc Nephrol 2 (2007) 883-888
32. Abate N., Chandalia M., Cabo-Chan Jr. A.V., et al. The metabolic syndrome and uric acid nephrolithiasis: Novel features of renal manifestation of insulin resistance. Kidney Int 65 (2004) 386-392
33. Takahashi S., Inokuchi T., Kobayashi T., et al. Relationship between insulin resistance and low urinary pH in patients with gout, and effects of PPAR alpha agonists on urine pH. Horm Metab Res 39 (2007) 511-514
34. Baddeley R.M. An epilogue to jejunoileal bypass. World J Surg 9 (1985) 842-849
35. Payne J.H., Dewind L.T., and Commons R.R. Metabolic observations in patients with jejunocolic shunts. Am J Surg 106 (1963) 273-289
36. Dickstein S.S., and Frame B. Urinary tract calculi after intestinal shunt operations for the treatment of obesity. Surg Gynecol Obstet 136 (1973) 257-260
37. Worcester E.M. Stones from bowel disease. Endocrinol Metab Clin North Am 31 (2002) 979-999
38. Smith L.H., Fromm H., and Hofmann A.F. Acquired hyperoxaluria, nephrolithiasis, and intestinal disease. Description of a syndrome. N Engl J Med 286 (1972) 1371-1375
39. Requarth J.A., Burchard K.W., Colacchio T.A., et al. Long-term morbidity following jejunoileal bypass. The continuing potential need for surgical reversal. Arch Surg 130 (1995) 318-325
40. Nordenvall B., Backman L., Larsson L., et al. Urine composition following jejunoileal bypass. Eur Urol 9 (1983) 35-39
41. Stauffer J.Q., Humphreys M.H., and Weir G.J. Acquired hyperoxaluria with regional enteritis after ileal resection. Role of dietary oxalate. Ann Intern Med 79 (1973) 383-391
42. Earnest D.L., Johnson G., Williams H.E., et al. Hyperoxaluria in patients with ileal resection: An abnormality in dietary oxalate absorption. Gastroenterology 66 (1974) 1114-1122
43. Dobbins J.W., and Binder H.J. Importance of the colon in enteric hyperoxaluria. N Engl J Med 296 (1977) 298-301
44. Kathpalia S.C., Favus M.J., and Coe F.L. Evidence for size and charge permselectivity of rat ascending colon. Effects of ricinoleate and bile salts on oxalic acid and neutral sugar transport. J Clin Invest 74 (1984) 805-811
45. Puzziferri N., Blankenship J., and Wolfe B.M. Surgical treatment of obesity. Endocrine 29 (2006) 11-19
46. Santry H.P., Gillen D.L., and Lauderdale D.S. Trends in bariatric surgical procedures. JAMA 294 (2005) 1909-1917
47. Nelson W.K., Houghton S.G., Milliner D.S., et al. Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy: Potentially serious and unappreciated complications of Roux-en-Y gastric bypass. Surg Obesity Rel Dis (2005) 481-485
48. Nasr SH, D'Agati VD, Said SM, et al: Oxalate nephropathy complicating Roux-en-Y gastric bypass: An underrecognized cause of irreversible renal failure. Clin J Am Soc Nephrol 2008 (in press)
49. Asplin J.R., and Coe F.L. Hyperoxaluria in kidney stone formers treated with modern bariatric surgery. J Urol 177 (2007) 565-569
50. Sinha M.K., Collazo-Clavell M.L., Rule A., et al. Hyperoxaluric nephrolithiasis is a complication of Roux-en-Y gastric bypass surgery. Kidney Int 72 (2007) 100-107
51. Duffey B.G., Pedro R.N., Makhlouf A., et al. Roux-en-Y gastric bypass is associated with early increased risk factors for development of calcium oxalate nephrolithiasis. J Am Coll Surg 206 (2008) 1145-1153
52. Patel BN, Passman CM, Fernandez A, et al: Prevalence of hyperoxaluria after bariatric surgery. J Urol 2008 (in press)
53. Durrani O., Morrisroe S., Jackman S., et al. Analysis of stone disease in morbidly obese patients undergoing gastric bypass surgery. J Endourol 20 (2006) 749-752
54. Encinosa W.E., Bernard D.M., Chen C.C., et al. Healthcare utilization and outcomes after bariatric surgery. Med Care 44 (2006) 706-712
55. Evan A.P., Lingeman J.E., Coe F.L., et al. Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest 111 (2003) 607-616
56. Evan A.P., Coe F.L., Gillen D., et al. Renal intratubular crystals and hyaluronan staining occur in stone formers with bypass surgery but not with idiopathic calcium oxalate stones. Anat Rec 291 (2008) 325-334
57. Jiang Z., Asplin J.R., Evan A.P., et al. Calcium oxalate urolithiasis in mice lacking anion transporter Slc26a6. Nat Genet 38 (2006) 474-478
58. Allison M.J., Cook H.M., Milne D.B., et al. Oxalate degradation by gastrointestinal bacteria from humans. J Nutr 116 (1986) 455-460
59. Foster G.D., Wyatt H.R., Hill J.O., et al. A randomized trial of a low-carbohydrate diet for obesity. N Engl J Med 348 (2003) 2082-2090
60. Shai I., Schwarzfuchs D., Henkin Y., et al. Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med 359 (2008) 229-241
61. Walker R.M., and Linkswiler H.M. Calcium retention in the adult human male as affected by protein intake. J Nutr 102 (1972) 1297-1302
62. Allen L.H., Oddoye E.A., and Margen S. Protein-induced hypercalciuria: A longer term study. Am J Clin Nutr 32 (1979) 741-749
63. Licata A.A., Bou E., Bartter F.C., et al. Effects of dietary protein on urinary calcium in normal subjects and in patients with nephrolithiasis. Metabolism 28 (1979) 895-900
64. Breslau N.A., Brinkley L., Hill K.D., et al. Relationship of animal protein-rich diet to kidney stone formation and calcium metabolism. J Clin Endocrinol Metab 66 (1988) 140-146
65. Reddy S.T., Wang C.Y., Sakhaee K., et al. Effect of low-carbohydrate high-protein diets on acid-base balance, stone-forming propensity, and calcium metabolism. Am J Kidney Dis 40 (2002) 265-274
66. Ferraz R.R., Tiselius H.G., and Heilberg I.P. Fat malabsorption induced by gastrointestinal lipase inhibitor leads to an increase in urinary oxalate excretion. Kidney Int 66 (2004) 676-682
67. Sarica K., Akarsu E., Erturhan S., et al. Evaluation of urinary oxalate levels in patients receiving gastrointestinal lipase inhibitor. Obesity 16 (2008) 1579-1584
68. Singh A., Sarkar S.R., Gaber L.W., et al. Acute oxalate nephropathy associated with orlistat, a gastrointestinal lipase inhibitor. Am J Kidney Dis 49 (2007) 153-157